The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
FindCure Biosciences (ZhongShan) Co., Ltd.
FindCure Biosciences (ZhongShan) Co., Ltd.
Hoffmann-La Roche
University of California, Irvine
ViroMissile, Inc.
AstraZeneca
Washington University School of Medicine
Institut Curie
Adela, Inc
Perspective Therapeutics
Eli Lilly and Company
UNICANCER
University of Illinois at Chicago
TScan Therapeutics, Inc.
UNC Lineberger Comprehensive Cancer Center
Actym Therapeutics, Inc.
British Columbia Cancer Agency
Washington University School of Medicine
Washington University School of Medicine
Turning Point Therapeutics, Inc.
University of California, Irvine
Cancer Research UK
Tempus AI
Elevation Oncology
Labcorp Corporation of America Holdings, Inc
Intensity Therapeutics, Inc.
Cedars-Sinai Medical Center
Sheffield Teaching Hospitals NHS Foundation Trust
Cyteir Therapeutics, Inc.
University of California, Davis
Memorial Sloan Kettering Cancer Center
Taiho Pharmaceutical Co., Ltd.
European Organisation for Research and Treatment of Cancer - EORTC
Xencor, Inc.
Second Affiliated Hospital of Guangzhou Medical University
Cedars-Sinai Medical Center
Innolake Biopharm
Presage Biosciences
Pfizer
Adaptimmune
Emory University
Kineta Inc.
Shanghai Yunying Medical Technology
Prelude Therapeutics
Quadriga Biosciences, Inc.
Ludwig Institute for Cancer Research
Roswell Park Cancer Institute
Presage Biosciences
Oncovir, Inc.
SpeciCare
University Hospital Tuebingen